Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000105

Chief Legal Officer sold 2,920 shares at $20.67 ($60,350)

  • Chief Legal Officer acquired 7,674 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-30 Exercise or conversion : show line 1 in the form +1,924 21,762 D
2024-07-30 Exercise or conversion : show line 2 in the form +2,000 23,762 D
2024-07-30 Exercise or conversion : show line 3 in the form +3,750 27,512 D
2024-07-30 Sale : show line 4 in the form −2,920 $20.67 $60,350 24,592 D
Open-market sales · 2,920 sh · avg $20.67 · $60,350

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-07-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −1,924 11,545 D
2024-07-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −2,000 14,000 D
2024-07-30 Exercise or conversion : show line 7 in the form Restricted Stock Units −3,750 41,250 D
Loading xslF345X05/wk-form4_1722380764.xml…